Stock Under $10 with 50-100% upside potential - 14 Days FREE!

4 Stocks Under $5 Soaring Higher

Stock quotes in this article: FCEL, ZGNX, ISR, LDK 

IsoRay

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

IsoRay (ISR) develops, manufactures and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases. This stock is trading up 11% to $1.30 in recent trading.

Today's Range: $1.17-$1.59

52-Week Range: $0.38-$1.49

Volume: 5.8 million

Three-Month Average Volume: 137,976

>>5 Stocks Poised for Breakouts

From a technical perspective, ISR is skyrocketing here with monster volume. This move is a continuation of recent upside momentum, since ISR has moved up from 61 cents to today's high of $1.60 in just the last three trading sessions. Today's large spike has also pushed ISR briefly into 52-week-high territory, and the stock has started to challenge some major past overhead resistance at $1.49.

Traders should now look for long-biased trades if ISR can manage to sustain a move or close above $1.49 to $1.60 with high-volume. On volume that's near or above 137,976 shares, look for ISR to challenge its next major overhead resistance levels at $1.73 to $1.89 or possibly trade north of $2.

On the flipside, I would avoid any long trades in ISR if it moves back below today's low of $1.17 with heavy volume.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 15,354.40 121.18 0.80%
NASDAQ 3,498.97 33.73 0.97%
S&P 500 1,667.47 17.00 1.03%
US 10 Yr 1.949% +0.084

Brokerage Partners

Advertising Partners
Special Features

Free Newsletters from TheStreet

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy. Manage Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs